Literature DB >> 17360787

Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan.

Ming-Yuh Shiau, Mei-Kuei Lo, Cheng-Pei Chang, Tzi-Peng Yang, Kuo-Ting Ho, Yih-Hsin Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17360787      PMCID： PMC1856035          DOI： 10.1136/ard.2006.065888

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis.

Authors:  A Milicic; F Lindheimer; S Laval; M Rudwaleit; H Ackerman; P Wordsworth; T Hohler; M A Brown
Journal:  Genes Immun       Date:  2000-10       Impact factor: 2.676

2.  Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese.

Authors:  C-T Chou; A E Timms; J C C Wei; W C Tsai; B P Wordsworth; M A Brown
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

3.  TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.

Authors:  S González; J C Torre-Alonso; J Martínez-Borra; J A Fernández Sánchez; A López-Vazquez; A Rodríguez Pérez; C López-Larrea
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

Review 4.  The interplay of nature versus nurture in predisposition to the rheumatic diseases.

Authors:  J D Reveille
Journal:  Rheum Dis Clin North Am       Date:  1993-02       Impact factor: 2.670

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.

Authors:  M Rudwaleit; S Siegert; Z Yin; J Eick; A Thiel; A Radbruch; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

7.  Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis.

Authors:  E L Kaijzel; B M Brinkman; M V van Krugten; L Smith; T W Huizinga; G M Verjans; F C Breedveld; C L Verweij
Journal:  Hum Immunol       Date:  1999-02       Impact factor: 2.850

8.  Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals.

Authors:  T Höhler; T Schäper; P M Schneider; K H Meyer zum Büschenfelde; E Märker-Hermann
Journal:  Arthritis Rheum       Date:  1998-08

9.  HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients.

Authors:  J C C Wei; W C Tsai; H S Lin; C Y Tsai; C T Chou
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580
  9 in total
  14 in total

1.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

2.  Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia.

Authors:  C Romero-Sánchez; J Londoño; G Delgado; D A Jaimes; J De Avila; A Mora; M Avila; J Castellanos; I Briceño; R Valle-Oñate
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 3.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

Review 4.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

5.  Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population.

Authors:  Won-Tae Chung; Jung-Yoon Choe; Won Cheoul Jang; Su Min Park; Young Chang Ahn; Il Kyu Yoon; Tae-Hwan Kim; Youn-Hyoung Nam; Sung-Hoon Park; Sung-Won Lee; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

Review 6.  Lack of association between TNF polymorphism and ankylosing spondylitis susceptibility in HLA-B27-positive population: a meta-analysis.

Authors:  Yanyan Bai; Hongsheng Sun; Naiwen Hu; Dongxia Liu; Na Zhao; Xia Wang
Journal:  Eur Spine J       Date:  2021-06-08       Impact factor: 3.134

7.  The synergistic role of TNFA - 308G/A and IL10 - 1082A/G polymorphisms in ankylosing spondylitis.

Authors:  Mariana Ivanova; Irena Manolova; Rumen Stoilov; Spaska Stanilova
Journal:  Rheumatol Int       Date:  2021-09-04       Impact factor: 2.631

8.  Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice.

Authors:  Kang Liu; Lianguo Wu; Xiaolin Shi; Fengqing Wu
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

9.  Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis.

Authors:  James Cheng-Chung Wei; Jeng-Hsien Yen; Suh-Hang Hank Juo; Wei-Chiao Chen; Yu-Shiuan Wang; Yi-Ching Chiu; Tusty-Jiuan Hsieh; Yuh-Cherng Guo; Chun-Huang Huang; Ruey-Hong Wong; Hui-Po Wang; Ke-Li Tsai; Yang-Chang Wu; Hsueh-Wei Chang; Edward Hsi; Wei-Pin Chang; Wei-Chiao Chang
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

Review 10.  A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Authors:  Masoud Mahdinejad-Yazdi; Mohammad Reza Sobhan; Seyed Alireza Dastgheib; Reza Bahrami; Seyed Hossein Shaker; Hamid Mirjalili; Jalal Sadeghizadeh-Yazdi; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.